Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lillicrap

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2014
First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management SystemA N Traore, A K C Chan, K E Webert, et al.
Journal of Thrombosis and Haemostasis : JTH|April 29, 2017
Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24M L Bowman, F G Pluthero, A Tuttle, et al.
Thrombosis and Haemostasis|October 6, 2000
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assayJ A Dean, V S Blanchette, M D Carcao, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2017
Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A miceJ D Lai, D Cartier, R B Hartholt, et al.
Environmental Toxicology and Chemistry|January 10, 2004
A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticalsThomas H Hutchinson, Sarah Barrett, Mary Buzby, et al.
British Journal of Haematology|December 12, 2001
The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarctionR Di Bitondo, C L Cameron, M E Daly, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|January 9, 2008
Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas)Matthew J Winter, Adam D Lillicrap, John E Caunter, et al.
Archives of Neurology|December 29, 1998
Prothrombotic disorders in infants and children with cerebral thromboembolismG deVeber, P Monagle, A Chan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2014
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicityD Matino, D Lillicrap, J Astermark, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2014
First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management SystemA N Traore, A K C Chan, K E Webert, et al.
Journal of Thrombosis and Haemostasis : JTH|April 29, 2017
Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24M L Bowman, F G Pluthero, A Tuttle, et al.
Thrombosis and Haemostasis|October 6, 2000
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assayJ A Dean, V S Blanchette, M D Carcao, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2017
Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A miceJ D Lai, D Cartier, R B Hartholt, et al.
Environmental Toxicology and Chemistry|January 10, 2004
A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticalsThomas H Hutchinson, Sarah Barrett, Mary Buzby, et al.
British Journal of Haematology|December 12, 2001
The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarctionR Di Bitondo, C L Cameron, M E Daly, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|January 9, 2008
Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas)Matthew J Winter, Adam D Lillicrap, John E Caunter, et al.
Archives of Neurology|December 29, 1998
Prothrombotic disorders in infants and children with cerebral thromboembolismG deVeber, P Monagle, A Chan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2014
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicityD Matino, D Lillicrap, J Astermark, et al.
Pageof 14